The Association Between Temporal Atrophy and Episodic Memory Is Moderated by Education in a Multi-Center Memory Clinic Sample.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
medline: 28 3 2023
pubmed: 14 2 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

Cognitive reserve (CR) is hypothesized to partially explain the discrepancy between Alzheimer's disease related brain pathology and cognitive performance. Educational attainment is often used as a proxy for CR. To examine the association of years of education and the relationship between atrophy in the medial temporal lobe and episodic memory, in a cross-sectional ecological multi-center memory clinic cohort. Included patients (n = 702) had undergone memory clinic examination and were diagnosed with subjective cognitive impairment (n = 99), mild cognitive impairment (n = 471), or dementia (n = 132). Total years of education were used as a moderating variable and neuropathology was operationalized as visual ratings of medial temporal lobe atrophy (MTA) on magnetic resonance imaging and computer tomography images. Weighted least squares regression and multiple regression were used to analyze moderation and the effect of education separately by diagnostic group. A composite score of two episodic memory tests constituted the dependent variable. After controlling for age and gender the interaction term between MTA and years of education was significant indicating moderation. In particular, the regression model showed that at low levels of MTA, high education individuals had better episodic memory performance. However, at higher MTA levels, high education individuals had the lowest episodic memory performance. Education had a significant positive effect on episodic memory in SCI and MCI, but not dementia. These results extend the findings of education moderating the effect of MTA on cognition to a naturalistic memory clinic setting. Implications of the findings for theories on CR are discussed.

Sections du résumé

BACKGROUND
Cognitive reserve (CR) is hypothesized to partially explain the discrepancy between Alzheimer's disease related brain pathology and cognitive performance. Educational attainment is often used as a proxy for CR.
OBJECTIVE
To examine the association of years of education and the relationship between atrophy in the medial temporal lobe and episodic memory, in a cross-sectional ecological multi-center memory clinic cohort.
METHODS
Included patients (n = 702) had undergone memory clinic examination and were diagnosed with subjective cognitive impairment (n = 99), mild cognitive impairment (n = 471), or dementia (n = 132). Total years of education were used as a moderating variable and neuropathology was operationalized as visual ratings of medial temporal lobe atrophy (MTA) on magnetic resonance imaging and computer tomography images. Weighted least squares regression and multiple regression were used to analyze moderation and the effect of education separately by diagnostic group. A composite score of two episodic memory tests constituted the dependent variable.
RESULTS
After controlling for age and gender the interaction term between MTA and years of education was significant indicating moderation. In particular, the regression model showed that at low levels of MTA, high education individuals had better episodic memory performance. However, at higher MTA levels, high education individuals had the lowest episodic memory performance. Education had a significant positive effect on episodic memory in SCI and MCI, but not dementia.
CONCLUSION
These results extend the findings of education moderating the effect of MTA on cognition to a naturalistic memory clinic setting. Implications of the findings for theories on CR are discussed.

Identifiants

pubmed: 36776050
pii: JAD220741
doi: 10.3233/JAD-220741
pmc: PMC10041436
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-614

Références

Lancet. 2015 Jun 6;385(9984):2255-63
pubmed: 25771249
J Int Neuropsychol Soc. 2021 May;27(5):401-411
pubmed: 33455611
Alzheimers Dement. 2019 Feb;15(2):185-193
pubmed: 30321506
Alzheimers Dement. 2020 Jul;16(7):1078-1094
pubmed: 32627328
Sci Rep. 2021 Feb 23;11(1):4356
pubmed: 33623075
J Neurol. 2007 Jun;254(6):774-81
pubmed: 17404777
Neurobiol Aging. 2017 Dec;60:164-172
pubmed: 28968586
PLoS One. 2012;7(6):e38268
pubmed: 22675535
Biochim Biophys Acta. 2016 May;1862(5):878-86
pubmed: 26769363
Insights Imaging. 2017 Feb;8(1):79-90
pubmed: 28004274
Ann Clin Transl Neurol. 2020 Aug;7(8):1307-1317
pubmed: 32856790
Am J Geriatr Psychiatry. 2009 Dec;17(12):1050-8
pubmed: 20104061
BMC Geriatr. 2020 Mar 6;20(1):93
pubmed: 32138686
Am J Geriatr Psychiatry. 2014 Nov;22(11):1336-45
pubmed: 24021219
Alzheimers Dement (Amst). 2017 Feb 09;7:69-87
pubmed: 28275702
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967-72
pubmed: 1431963
Front Hum Neurosci. 2021 Sep 09;15:723728
pubmed: 34566608
Front Aging Neurosci. 2021 Jan 21;12:607685
pubmed: 33551788
Lancet. 2015 Oct 24;386(10004):1698-706
pubmed: 26595643
Dement Geriatr Cogn Disord. 2010;29(1):75-81
pubmed: 20110703
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
Neurotox Res. 2010 Nov;18(3-4):339-46
pubmed: 20352396
Addict Behav. 2019 Jul;94:99-108
pubmed: 30262130
J Clin Epidemiol. 2019 Jun;110:63-73
pubmed: 30878639
BMC Med. 2015 Jul 21;13:132
pubmed: 26195085
Gerontologist. 1997 Apr;37(2):150-6
pubmed: 9127971
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Appl Neuropsychol Adult. 2018 Sep-Oct;25(5):473-485
pubmed: 28594578
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Neurology. 2021 Oct 26;97(17):e1695-e1706
pubmed: 34493618
Alzheimers Dement. 2014 Oct;10(5 Suppl):S299-305
pubmed: 24210526
J Int Neuropsychol Soc. 2006 Jan;12(1):147-52
pubmed: 16433954
Stroke. 2020 Jan;51(1):99-107
pubmed: 31822247
J Clin Exp Neuropsychol. 2015;37(3):253-64
pubmed: 25748936
J Alzheimers Dis. 2020;76(2):671-679
pubmed: 32538838
Radiology. 2009 Oct;253(1):174-83
pubmed: 19635835
Neurobiol Aging. 2019 Dec;84:109-118
pubmed: 31539647
J Alzheimers Dis. 2009;17(4):855-62
pubmed: 19542606
Neuropsychopharmacology. 2010 Jan;35(1):86-104
pubmed: 19776728
BMC Med. 2014 Nov 11;12:206
pubmed: 25385447
Front Aging Neurosci. 2018 Nov 08;10:361
pubmed: 30467475
Neuropsychologia. 2009 Aug;47(10):2015-28
pubmed: 19467352

Auteurs

Måns Gyllenhammar (M)

Women's Health and Allied Health Professionals Theme, Karolinska University Hospital, Stockholm, Sweden.

Anna Rennie (A)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Daniel Ferreira Padilla (DF)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

John Wallert (J)

Center for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Anders Rydström (A)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Aging Research Center, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.

Lars-Olof Wahlund (LO)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Maria Eriksdotter (M)

Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.

Eric Westman (E)

Women's Health and Allied Health Professionals Theme, Karolinska University Hospital, Stockholm, Sweden.
Department of Neuroimaging, Center for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Urban Ekman (U)

Women's Health and Allied Health Professionals Theme, Karolinska University Hospital, Stockholm, Sweden.
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH